ARID4B and cancer: Since ARID4B overexpression was found to be of prognostic value in other types of cancer [45,46,47], we explored the protein expression of ARID4B in all cell lines used in our CRISPR-Cas9 knockout screens, and found no significant differences (Figure 3H,I).